<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
   <PubmedArticle>
      <MedlineCitation Owner="NLM" Status="MEDLINE">
         <PMID Version="1">30445121</PMID>
         <DateCompleted>
            <Year>2020</Year>
            <Month>02</Month>
            <Day>10</Day>
         </DateCompleted>
         <DateRevised>
            <Year>2020</Year>
            <Month>03</Month>
            <Day>09</Day>
         </DateRevised>
         <Article PubModel="Print-Electronic">
            <Journal>
               <ISSN IssnType="Electronic">1872-9096</ISSN>
               <JournalIssue CitedMedium="Internet">
                  <Volume>162</Volume>
                  <PubDate>
                     <Year>2019</Year>
                     <Month>02</Month>
                  </PubDate>
               </JournalIssue>
               <Title>Antiviral research</Title>
               <ISOAbbreviation>Antiviral Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Vaccinating against monkeypox in the Democratic Republic of the Congo.</ArticleTitle>
            <Pagination>
               <MedlinePgn>171-177</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0166-3542(18)30596-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2018.11.004</ELocationID>
            <Abstract>
               <AbstractText>
                  Healthcare-associated transmission of monkeypox has been observed on multiple occasions in areas where the disease is endemic. Data collected by the US Centers for Disease Control and Prevention (CDC) from an ongoing CDC-supported program of enhanced surveillance in the Tshuapa Province of the Democratic Republic of the Congo, where the annual incidence of human monkeypox is estimated to be 3.5-5/10,000, suggests that there is approximately one healthcare worker infection for every 100 confirmed monkeypox cases. Herein, we describe a study that commenced in February 2017, the intent of which is to evaluate the effectiveness, immunogenicity, and safety of a third-generation smallpox vaccine, IMVAMUNE
                  <sup>®</sup>
                  , in healthcare personnel at risk of monkeypox virus (MPXV) infection. We describe procedures for documenting exposures to monkeypox virus infection in study participants, and outline lessons learned that may be of relevance for studies of other investigational medical countermeasures in hard to reach, under-resourced populations.
               </AbstractText>
               <CopyrightInformation>Copyright © 2018. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
               <Author ValidYN="Y">
                  <LastName>Petersen</LastName>
                  <ForeName>Brett W</ForeName>
                  <Initials>BW</Initials>
                  <AffiliationInfo>
                     <Affiliation>U.S. Centers for Disease Control and Prevention, Atlanta, USA. Electronic address: bpetersen@cdc.gov.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Kabamba</LastName>
                  <ForeName>Joelle</ForeName>
                  <Initials>J</Initials>
                  <AffiliationInfo>
                     <Affiliation>U.S. Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of the Congo.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>McCollum</LastName>
                  <ForeName>Andrea M</ForeName>
                  <Initials>AM</Initials>
                  <AffiliationInfo>
                     <Affiliation>U.S. Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Lushima</LastName>
                  <ForeName>Robert Shongo</ForeName>
                  <Initials>RS</Initials>
                  <AffiliationInfo>
                     <Affiliation>Hemorrhagic Fever and Monkeypox Program, Ministry of Health, Kinshasa, Democratic Republic of the Congo.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Wemakoy</LastName>
                  <ForeName>Emile Okitolonda</ForeName>
                  <Initials>EO</Initials>
                  <AffiliationInfo>
                     <Affiliation>Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Muyembe Tamfum</LastName>
                  <ForeName>Jean-Jacques</ForeName>
                  <Initials>JJ</Initials>
                  <AffiliationInfo>
                     <Affiliation>National Institute for Biomedical Research, Kinshasa, Democratic Republic of the Congo.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Nguete</LastName>
                  <ForeName>Beatrice</ForeName>
                  <Initials>B</Initials>
                  <AffiliationInfo>
                     <Affiliation>Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Hughes</LastName>
                  <ForeName>Christine M</ForeName>
                  <Initials>CM</Initials>
                  <AffiliationInfo>
                     <Affiliation>U.S. Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Monroe</LastName>
                  <ForeName>Benjamin P</ForeName>
                  <Initials>BP</Initials>
                  <AffiliationInfo>
                     <Affiliation>U.S. Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation>
                  </AffiliationInfo>
               </Author>
               <Author ValidYN="Y">
                  <LastName>Reynolds</LastName>
                  <ForeName>Mary G</ForeName>
                  <Initials>MG</Initials>
                  <AffiliationInfo>
                     <Affiliation>U.S. Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation>
                  </AffiliationInfo>
               </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
               <Grant>
                  <GrantID>CC999999</GrantID>
                  <Agency>Intramural CDC HHS</Agency>
                  <Country>United States</Country>
               </Grant>
               <Grant>
                  <GrantID>U01 CK000539</GrantID>
                  <Acronym>CK</Acronym>
                  <Agency>NCEZID CDC HHS</Agency>
                  <Country>United States</Country>
               </Grant>
            </GrantList>
            <PublicationTypeList>
               <PublicationType UI="D016428">Journal Article</PublicationType>
               <PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
               <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
               <Year>2018</Year>
               <Month>11</Month>
               <Day>14</Day>
            </ArticleDate>
         </Article>
         <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Antiviral Res</MedlineTA>
            <NlmUniqueID>8109699</NlmUniqueID>
            <ISSNLinking>0166-3542</ISSNLinking>
         </MedlineJournalInfo>
         <ChemicalList>
            <Chemical>
               <RegistryNumber>0</RegistryNumber>
               <NameOfSubstance UI="D012900">Smallpox Vaccine</NameOfSubstance>
            </Chemical>
            <Chemical>
               <RegistryNumber>0</RegistryNumber>
               <NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance>
            </Chemical>
            <Chemical>
               <RegistryNumber>TU8J357395</RegistryNumber>
               <NameOfSubstance UI="C527606">imvamune</NameOfSubstance>
            </Chemical>
         </ChemicalList>
         <CitationSubset>IM</CitationSubset>
         <MeshHeadingList>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D002986">Clinical Trials as Topic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" Type="Geographic" UI="D015023">Democratic Republic of the Congo</DescriptorName>
               <QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="Y" UI="D006282">Health Personnel</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D006295">Health Resources</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D000071497">Immunogenicity, Vaccine</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D045908">Monkeypox</DescriptorName>
               <QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
               <QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D008993">Monkeypox virus</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D009784">Occupational Diseases</DescriptorName>
               <QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
               <QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
               <QualifierName MajorTopicYN="N" UI="Q000821">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D012424">Rural Population</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D012900">Smallpox Vaccine</DescriptorName>
               <QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
               <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D014611">Vaccination</DescriptorName>
            </MeshHeading>
            <MeshHeading>
               <DescriptorName MajorTopicYN="N" UI="D014613">Vaccines, Attenuated</DescriptorName>
               <QualifierName MajorTopicYN="N" UI="Q000008">administration &amp; dosage</QualifierName>
               <QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
            </MeshHeading>
         </MeshHeadingList>
         <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Clinical trial</Keyword>
            <Keyword MajorTopicYN="Y">Democratic Republic of the Congo</Keyword>
            <Keyword MajorTopicYN="Y">IMVAMUNE</Keyword>
            <Keyword MajorTopicYN="Y">Monkeypox</Keyword>
            <Keyword MajorTopicYN="Y">Smallpox vaccine</Keyword>
         </KeywordList>
      </MedlineCitation>
      <PubmedData>
         <History>
            <PubMedPubDate PubStatus="received">
               <Year>2018</Year>
               <Month>10</Month>
               <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
               <Year>2018</Year>
               <Month>11</Month>
               <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
               <Year>2018</Year>
               <Month>11</Month>
               <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
               <Year>2018</Year>
               <Month>11</Month>
               <Day>18</Day>
               <Hour>6</Hour>
               <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
               <Year>2020</Year>
               <Month>2</Month>
               <Day>11</Day>
               <Hour>6</Hour>
               <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
               <Year>2018</Year>
               <Month>11</Month>
               <Day>17</Day>
               <Hour>6</Hour>
               <Minute>0</Minute>
            </PubMedPubDate>
         </History>
         <PublicationStatus>ppublish</PublicationStatus>
         <ArticleIdList>
            <ArticleId IdType="pubmed">30445121</ArticleId>
            <ArticleId IdType="pii">S0166-3542(18)30596-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.antiviral.2018.11.004</ArticleId>
            <ArticleId IdType="pmc">PMC6438175</ArticleId>
            <ArticleId IdType="mid">NIHMS1009764</ArticleId>
         </ArticleIdList>
         <ReferenceList>
            <Reference>
               <Citation>Vaccine. 2006 Mar 15;24(12):2065-70</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">16337719</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16262-7</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">20805472</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Vaccine. 2010 Feb 3;28(5):1209-16</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">19944151</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Int Health. 2013 Dec;5(4):237-43</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">24246742</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>N Engl J Med. 1969 Nov 27;281(22):1201-8</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">4186802</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Lancet. 2015 Jan 17;385(9964):239-52</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">25242039</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Bull World Health Organ. 1972;46(5):593-7</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">4340218</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>J Virol. 2005 Jun;79(12):7845-51</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">15919938</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Ecohealth. 2017 Sep;14(3):564-574</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">28894977</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S221-6</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">18284362</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Vaccine. 2013 Jun 24;31(29):3025-33</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">23664987</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Vaccine. 2007 Dec 12;25(51):8562-73</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">18036708</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>N Engl J Med. 2004 Jan 22;350(4):342-50</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">14736926</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Vaccine. 2015 Sep 22;33(39):5225-34</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">26143613</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Clin Infect Dis. 2014 Jan;58(2):260-7</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">24158414</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Clin Infect Dis. 2003 Mar 15;36(6):766-74</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">12627361</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Clin Infect Dis. 2012 Mar;54(6):832-40</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">22291103</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10889-94</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">18678911</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>PLoS One. 2013 Sep 05;8(9):e74816</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">24040344</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Emerg Infect Dis. 2017 Dec;23(13):</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">29155663</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>J Virol. 2011 Aug;85(15):7683-98</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">21632764</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>MMWR Morb Mortal Wkly Rep. 2016 Mar 18;65(10):257-62</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">26985679</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>South Med J. 2009 Jun;102(6):615-9</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">19434043</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>J Infect Dis. 2013 Mar 1;207(5):749-58</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">23225902</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Vaccine. 2011 Dec 30;29 Suppl 4:D60-4</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">22188935</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>J Infect Dis. 1970 Oct;122(4):303-9</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">4396189</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Curr Opin Virol. 2012 Jun;2(3):353-6</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">22709520</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">29543790</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>J Infect Dis. 2013 Jun 15;207(12):1888-97</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">23482644</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Bull World Health Organ. 1988;66(4):465-70</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">2844429</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S242-50</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">18284365</ArticleId>
               </ArticleIdList>
            </Reference>
            <Reference>
               <Citation>MMWR Recomm Rep. 2015 Feb 20;64(RR-02):1-26</Citation>
               <ArticleIdList>
                  <ArticleId IdType="pubmed">25695372</ArticleId>
               </ArticleIdList>
            </Reference>
         </ReferenceList>
      </PubmedData>
   </PubmedArticle>
</PubmedArticleSet>
